Exelixis
EXEL
#1805
Rank
โ‚น1.031 T
Marketcap
โ‚น3,846
Share price
-1.36%
Change (1 day)
22.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company